IOI Oleo GmbH enjoys an excellent reputation worldwide as a manufacturer of high-quality, lipid-based additives. In order to ensure that we maintain our standards for the highest quality and to comply with the guideline values of national and international pharmacopoeias, we attach great importance to the selection of the raw [...]
The selection and qualification of a manufacturer of excipients and active ingredients is one of the main tasks of quality management, which aims, among other things, to ensure the manufacture of effective and safe pharmaceuticals. In this context, monographs serve as a guide to evaluate raw materials regarding their physico-chemical [...]
In November, the CPHI 2022 in Frankfurt, the leading trade fair for the pharmaceutical industry, finally ended our long absence from trade fairs. We were all very excited to finally see our customers, business partners and friends again, resume personal discussions and make new contacts. One topic was especially important [...]
Finally, the time has come! We will be live at the CPHI Worldwide with a booth. We had to wait until today to present our new trade fair appearance to you and are all the more pleased to welcome you from November 1st to 3rd, 2022 in Frankfurt. Because nothing [...]
Climate change in all its aspects is one of the greatest challenges of the 21st century and cannot be solved through political debates alone. The economy is an elementary component in achieving the climate goals. Therefore, the sustainable and environmentally conscious orientation of our company is an integral part of [...]
Topical uses of our specialty products are a pivotal component of our daily aspiration at IOI Oleo GmbH. The business units Pharma and Personal care have common history and share products and expertise to help customers developing high quality, sensorially appealing formulations.
In our last newsletter, we reported on our increased presence in Asia and were able to introduce four new colleagues to you. The recently concluded partnership with our new distributor DKSH for our pharmaceutical area underpins our commitment to our customers in the Asian markets.
According to a conservative estimate, approximately 1,000,000,000 (1 billion) individual patient doses are manufactured annually with our WITEPSOL® products for the application area of pain and fever management. This not only makes us proud, but also underlines our position as a global benchmark.
In 1843 the Englishman William Brockedon (1787 - 1854) applied for a patent for the tablet and caused “one of the most tremendous upheavals that the pharmacists have ever experienced”. Thereby active ingredients can be precisely dosed and are very stable, the taking is convenient, the production cheap and they [...]
A trend that we are seeing in the market in the USA is the improvement of patient compliance. "Take 1 tablet instead of having to think about regularly taking 3 tablets a day." A trend that we are seeing in the USA addresses just this topic. The goal is to [...]
Start
Products
Expertise
About us
People & Culture
IOI Oleo GmbH Herrengraben 31 20459 Hamburg
Start
Products
Expertise
About us
People & Culture
IOI Oleo GmbH Herrengraben 31 20459 Hamburg
IOI Oleo GmbH
Herrengraben 31
20459 Hamburg
